Newsroom homepage
-
Press ReleasesActions continue to protect the health and safety of nursing home residents
-
Fact Sheets
CMS is announcing a final Medicare national coverage determination (NCD) that covers Food and Drug Administration (FDA) approved monoclonal antibodies directed against amyloid for the treatment of Alzheimer’s disease (AD) when furnished in accordance to the Coverage Criteria
-
News Alert
Today, the Centers for Medicare & Medicaid Services (CMS) announced it will pay for a second COVID-19 booster shot of either the Pfizer-BioNTech or Moderna COVID-19 vaccines without cost sharing as it continues to provide coverage for this critical protection from the virus
-
Press Releases
The Biden-Harris Administration is announcing today that more than 59 million Americans with Medicare Part B, including those enrolled in a Medicare Advantage plan, now have access to Food and Drug Administration (FDA) approved, authorized, or cleared over-the-counter COVID-19
-
Fact Sheets
Today, the Centers for Medicare & Medicaid Services (CMS) released the Announcement of Calendar Year (CY) 2023 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies (the Rate Announcement). CMS’s goals for Medicare Advantage and Part D mirror our vision
-
Fact Sheets
Medicare has a new initiative that will cover up to eight over-the-counter COVID-19 tests each calendar month, at no cost to you.
Who’s eligible?
Medicare will cover these tests if you have Part B, including those enrolled in a Medicare Advantage plan.
If you are in a